Long-term outcomes
Between the LH and OH groups, no significant difference was found in 12-, 36-, and 60-month overall survival (respectively, 88.5%, 82.9%, and 71.8% vs. 83.7%, 74.3%, and 67.6%, p = 0.257) and disease-free survival (respectively, 77.2%, 53.3%, and 48.3% vs. 71.5%, 52.8%, and 39.7%, p = 0.509) (Figure 3A, B). In the favorable location subgroup analysis, the F-LH and F-OH groups demonstrated no significant difference in 12-, 36-, and 60-month overall survival (respectively, 90.7%, 88.1%, and 75.4% vs. 79.5%, 76.6%, and 70.4%, p = 0.184) and disease-free survival (respectively, 79.2%, 52.9%, and 49.1% vs. 73.9%, 54.7%, and 39.5%, p = 0.683) (Figure 3C, D).